New Key Statistics Module, Z-Score and F-Score
OTCPK:REGMY Key Ratios
| Market Cap $ M | 2,937.07 |
| Enterprise Value $ M | 6,372.86 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.79 |
| Price/Sales | 19.19 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -2.21 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -33.24 |
| EV-to-EBITDA | -33.24 |
| PEG | -- |
| Shares Outstanding M | 544.26 |
| Net Margin (%) | -99.35 |
| Operating Margin % | -96.01 |
| Pre-tax Margin (%) | -99.35 |
| Quick Ratio | 1.31 |
| Current Ratio | 1.96 |
| ROA % (ttm) | -11.44 |
| ROE % (ttm) | -15.62 |
| ROIC % (ttm) | -17.49 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.26 |
REGMY Number of Guru Trades
REGMY Volume of Guru Trades
Gurus Latest Trades with OTCPK:REGMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:REGMY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
RemeGen Co Ltd Insider Transactions
No Available Data
News about OTCPK:REGMY
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers